Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact on Survival of Early Detection of Recurrence in the Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

NCT04298619 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT04298619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04298619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact on Survival of Early Detection of Recurrence in the Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission
Lead sponsor
Federico II University
Phase
Observational
Overall status
Completed
Start date
June 30, 2001
Completion date
April 30, 2019
Enrollment
123 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

high risk, hodgkin lymphoma, relapse